Angio-oedema without hives, IgE and omalizumab

被引：1
作者：
Jauregui, I. [1 ]
Azofra, J. [2 ]
Diaz, C. [2 ]
Ferrer, M. [3 ]
机构：
[1] Hosp Univ Basurto, Dept Allergy, 18 Ave Montevideo, Bilbao 48013, Spain
[2] Hosp Cent Asturias, Dept Allergy, Oviedo, Spain
[3] Clin Univ Navarra, Dept Allergy, Pamplona, Spain
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2017年 / 42卷 / 04期
关键词：
URTICARIA;
D O I：
10.1111/ced.13079
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：431 / 432
页数：3
相关论文
共 28 条
  • [21] Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
    Maurer, Marcus
    Altrichter, Sabine
    Bieber, Thomas
    Biedermann, Tilo
    Braeutigam, Matthias
    Seyfried, Stefan
    Brehler, Randolf
    Grabbe, Juergen
    Hunzelmann, Nicolas
    Jakob, Thilo
    Jung, Andreas
    Kleine-Tebbe, Joerg
    Mempel, Martin
    Meurer, Michael
    Reich, Kristian
    Rueff, Franziska
    Schaekel, Knut
    Sengupta, Kaushik
    Sieder, Christian
    Simon, Jan C.
    Wedi, Bettina
    Zuberbier, Torsten
    Mahler, Vera
    Staubach, Petra
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (01) : 202 - U326
  • [22] Monitoring of thyroid function in patients who exhibit IgE against thyroperoxidase while taking omalizumab?
    Dreyfus, David H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (01) : 269 - 270
  • [23] Total IgE and atopic status in patients with severe chronic spontaneous urticaria unresponsive to omalizumab treatment
    Asero, Riccardo
    Ferrucci, Silvia
    Casazza, Giovanni
    Marzano, Angelo V.
    Cugno, Massimo
    ALLERGY, 2019, 74 (08) : 1561 - 1563
  • [24] Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count
    Tamer, Funda
    Erdogan, Fatma Gulru
    Rota, Didem Dincer
    Yildirim, Dilsun
    Kara, Yesim Akpinar
    ACTA DERMATOVENEROLOGICA CROATICA, 2019, 27 (02) : 101 - 106
  • [25] Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab
    Saavedra M.C.
    Sur S.
    Clinical and Molecular Allergy, 9 (1)
  • [26] IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies
    Barrios, D. M.
    Phillips, G. S.
    Geisler, A. N.
    Trelles, S. R.
    Markova, A.
    Noor, S. J.
    Quigley, E. A.
    Haliasos, H. C.
    Moy, A. P.
    Schram, A. M.
    Bromberg, J.
    Funt, S. A.
    Voss, M. H.
    Drilon, A.
    Hellmann, M. D.
    Comen, E. A.
    Narala, S.
    Patel, A. B.
    Wetzel, M.
    Jung, J. Y.
    Leung, D. Y. M.
    Lacouture, M. E.
    ANNALS OF ONCOLOGY, 2021, 32 (06) : 736 - 745
  • [27] The effect of at least 1-year use of omalizumab without interruption on relapse in patients with chronic spontaneous urticaria
    Su, Ozlem
    Bahali, Anil Gulsel
    Onsun, Nahide
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [28] Activation of Human Peripheral Basophils in Response to High IgE Antibody Concentrations without Antigens
    Yanase, Yuhki
    Matsuo, Yoshimi
    Kawaguchi, Tomoko
    Ishii, Kaori
    Tanaka, Akio
    Iwamoto, Kazumasa
    Takahagi, Shunsuke
    Hide, Michihiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (01):
123